SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19 (Protocol)

Caroline Hirsch, Sarah J. Valk, Vanessa Piechotta, Khai Li Chai, Lise J. Estcourt, Ina Monsef, Susanne Salomon, Eve Tomlinson, Maria Popp, Erica M. Wood, Cynthia So-Osman, David J. Roberts, Zoe McQuilten, Nicole Skoetz, Nina Kreuzberger

Research output: Contribution to journalArticleOtherpeer-review

18 Citations (Scopus)

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effectiveness and safety of SARS-CoV-2-neutralising mAbs, including mAb fragments, to prevent infection with SARS-CoV-2 causing COVID-19; and to maintain the currency of the evidence, using a living systematic review approach.

Original languageEnglish
Article numberCD014945
Number of pages23
JournalCochrane Database of Systematic Reviews
Volume2021
Issue number5
DOIs
Publication statusPublished - 20 May 2021

Cite this